| Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts V Agnusdei, S Minuzzo, C Frasson, A Grassi, F Axelrod, S Satyal, ... Leukemia 28 (2), 278-288, 2014 | 128 | 2014 |
| Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models S Valtorta, AL Dico, I Raccagni, D Gaglio, S Belloli, LS Politi, C Martelli, ... Oncotarget 8 (68), 113090, 2017 | 83 | 2017 |
| Inhibition of the hexosamine biosynthetic pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis F Ricciardiello, G Votta, R Palorini, I Raccagni, L Brunelli, A Paiotta, ... Cell death & disease 9 (3), 377, 2018 | 74 | 2018 |
| VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells M Curtarello, E Zulato, G Nardo, S Valtorta, G Guzzo, E Rossi, G Esposito, ... Cancer research 75 (1), 120-133, 2015 | 71 | 2015 |
| Human malignant mesothelioma is recapitulated in immunocompetent BALB/c mice injected with murine AB cells R Mezzapelle, E Rrapaj, E Gatti, C Ceriotti, FD Marchis, A Preti, ... Scientific Reports 6 (1), 22850, 2016 | 42 | 2016 |
| Translation imaging in Parkinson’s disease: focus on neuroinflammation S Belloli, M Morari, V Murtaj, S Valtorta, RM Moresco, MC Gilardi Frontiers in aging neuroscience 12, 152, 2020 | 34 | 2020 |
| Imaging temozolomide-induced changes in the myeloid glioma microenvironment C Foray, S Valtorta, C Barca, A Winkeler, W Roll, M Müther, S Wagner, ... Theranostics 11 (5), 2020, 2021 | 29 | 2021 |
| Identification of imaging biomarkers for the assessment of tumour response to different treatments in a preclinical glioma model A Lo Dico, C Martelli, S Valtorta, I Raccagni, C Diceglie, S Belloli, ... European Journal of Nuclear Medicine and Molecular Imaging 42, 1093-1105, 2015 | 29 | 2015 |
| Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis (N4-methylthiosemicarbazone) in preclinical models of cancer S Valtorta, S Belloli, F Sanvito, V Masiello, G Di Grigoli, C Monterisi, ... Journal of Nuclear Medicine 54 (7), 1106-1112, 2013 | 29 | 2013 |
| Time course of metabolic activity and cellular infiltration in a murine model of acid-induced lung injury V Zambelli, G Di Grigoli, M Scanziani, S Valtorta, M Amigoni, S Belloli, ... Intensive care medicine 38, 694-701, 2012 | 27 | 2012 |
| Characterization of preclinical models of prostate cancer using PET-based molecular imaging S Belloli, E Jachetti, RM Moresco, M Picchio, M Lecchi, S Valtorta, ... European journal of nuclear medicine and molecular imaging 36, 1245-1255, 2009 | 27 | 2009 |
| Molecular and cellular complexity of glioma. Focus on tumour microenvironment and the use of molecular and imaging biomarkers to overcome treatment resistance S Valtorta, D Salvatore, P Rainone, S Belloli, G Bertoli, RM Moresco International Journal of Molecular Sciences 21 (16), 5631, 2020 | 25 | 2020 |
| Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis L Cottone, A Capobianco, C Gualteroni, A Monno, I Raccagni, S Valtorta, ... Oncoimmunology 5 (5), e1122860, 2016 | 25 | 2016 |
| Regional Differences in Cerebral Glucose Metabolism After Cardiac Arrest and Resuscitation in Rats Using [18F]FDG Positron Emission Tomography and … A Putzu, S Valtorta, G Di Grigoli, M Haenggi, S Belloli, A Malgaroli, ... Neurocritical care 28, 370-378, 2018 | 24 | 2018 |
| The driving role of the Cdk5/Tln1/FAKS732 axis in cancer cell extravasation dissected by human vascularized microfluidic models M Gilardi, S Bersini, S Valtorta, M Proietto, M Crippa, ... Biomaterials 276, 120975, 2021 | 23 | 2021 |
| Glycine N‐Methylation in NGR‐Tagged Nanocarriers Prevents Isoaspartate Formation and Integrin Binding without Impairing CD13 Recognition and Tumor Homing A Corti, AM Gasparri, M Ghitti, A Sacchi, F Sudati, M Fiocchi, V Buttiglione, ... Advanced functional materials 27 (36), 1701245, 2017 | 23 | 2017 |
| Validation of an Engineered Cell Model for In Vitro and In Vivo HIF-1α Evaluation by Different Imaging Modalities A Lo Dico, S Valtorta, C Martelli, S Belloli, U Gianelli, D Tosi, S Bosari, ... Molecular imaging and biology 16, 210-223, 2014 | 22 | 2014 |
| [18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer I Raccagni, S Belloli, S Valtorta, A Stefano, L Presotto, C Pascali, A Bogni, ... PLoS One 13 (5), e0197754, 2018 | 21 | 2018 |
| A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer S Valtorta, G Nicolini, F Tripodi, C Meregalli, G Cavaletti, F Avezza, ... Investigational new drugs 32, 1123-1133, 2014 | 19 | 2014 |
| Frontiers in anti-cancer drug discovery: Challenges and perspectives of metformin as anti-angiogenic add-on therapy in glioblastoma L Guarnaccia, G Marfia, MM Masseroli, SE Navone, M Balsamo, M Caroli, ... Cancers 14 (1), 112, 2021 | 18 | 2021 |
